Toggle navigation
Home
Search
Services
Blog
Contact
About
Antineoplastic Copper Salicylates
Willingham, William M.
University of Arkansas for Medical Sciences, Little Rock, AR, United States
Search 45 grants from William Willingham
Search grants from University of Arkansas for Medical Sciences
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Training in Environmental Toxicology
Immunological Training in Rheumatology and Dermatology
Minority High School Student Research Apprentice Program
Phase I and Clinical Studies of Anti-Cancer Agents
Biomedical Research Support Grant
Recently added grants:
Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy
Northwestern University Lead Academic Participating Site
UM LAPs - UG1 Grant
UG1 - NCTN (Network Lead)
Identifying the pro-metastatic mechanisms of neutrophil extracellular traps
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
MARC (NRSA) Faculty Fellowships (F34)
Project #
5F34GM009562-02
Application #
3057294
Study Section
Minority Access To Research Careers Review Committee (MRC)
Project Start
1985-06-04
Project End
Budget Start
1985-06-04
Budget End
1985-08-02
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
University of Arkansas for Medical Sciences
Department
Type
Schools of Pharmacy
DUNS #
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Publications
Willingham, W M; Sorenson, J R
(1988)
Copper(II)ethylenediaminetetraacetate does disproportionate superoxide.
Biochem Biophys Res Commun 150:252-8
Comments
Be the first to comment on William Willingham's grant